img
Call Now For Enquiry
Whatspp Now For Inquiry

Achievement Details

Valve-in-Valve Non-Surgical Transcatheter Mitral Valve Replacement (TMVR) by Dr. Rufus Demel
Structural Heart & Transcatheter Valve Therapies

Life-Saving Milestone: Dr. Rufus Successfully Performs Non-Surgical Valve-in-Valve TMVR in a High-Risk Patient with Prior Surgeries and Pacemaker

Clinical Summary (மருத்துவ சுருக்கம்):

A woman who had undergone multiple cardiac surgeries and had a pacemaker implanted was considered at very high risk for conventional Mitral Valve Replacement (MVR) surgery. She was successfully treated with a non-surgical Transcatheter Mitral Valve Replacement (TMVR) procedure.

"பலமுறை இதய அறுவை சிகிச்சைகள் மற்றும் பேஸ்மேக்கர் (pacemaker) பொருத்தப்பட்டிருந்த, மிட்ரல் வால்வு மாற்ற அறுவை சிகிச்சைக்கு (MVR) மிக அதிக ஆபத்துள்ள நிலையில் இருந்த ஒரு பெண்மணிக்கு, அறுவை சிகிச்சை இல்லா மிட்ரல் வால்வு மாற்று முறை (TMVR) வெற்றிகரமாக மேற்கொள்ளப்பட்டது."

In an extraordinary clinical breakthrough demonstrating the power of modern structural heart interventions, Dr. X. Rufus Demel successfully performed a complex, life-saving Valve-in-Valve Transcatheter Mitral Valve Replacement (TMVR) on a woman deemed at prohibitive, life-threatening risk for conventional redo open-heart surgery. Having endured multiple prior cardiac surgical operations and living with an implanted permanent pacemaker, the patient’s surgical bioprosthetic mitral valve had severely degenerated, precipitating acute cardiac compromise.

A conventional open-heart re-operation (re-do sternotomy) presents extreme challenges in patients with repeated previous thoracic surgeries. Extensive pericardial scar tissue, dense mediastinal adhesions, altered vascular geometry, and the delicate presence of indwelling pacemaker leads all exponentially multiply the danger of surgical re-entry, massive bleeding, and prolonged cardiopulmonary bypass complications. Faced with these severe surgical contraindications, Dr. Rufus and his clinical team selected a state-of-the-art, non-surgical catheter-based approach: delivering a new bioprosthetic valve directly inside the failed surgical valve frame with pinpoint fluoroscopic accuracy.

Valve-in-Valve TMVR Procedural Deployment

Key Clinical Benefits of Valve-in-Valve TMVR

  • 100% Non-Surgical & Minimally Invasive: Completely avoids sternotomy, heart-lung machine bypass, and chest incisions, offering a safe lifeline for high-risk patients.
  • Preservation of Pacemaker Leads: The catheter-based delivery route is meticulously navigated under real-time fluoroscopic imaging to safeguard existing cardiac pacing leads from dislodgement.
  • Immediate Hemodynamic Restoration: Deploys a new functioning valve within the degenerated surgical ring, instantly resolving mitral regurgitation and normalizing left atrial pressures.
  • Rapid Recovery & Minimal Hospital Stay: Patients typically experience minimal discomfort, bypass protracted ICU stays, and regain ambulatory independence within 24 to 48 hours.
  • Zero Sternotomy Wound Complications: Eliminates deep sternal wound infection risks, extensive blood transfusions, and prolonged ventilator dependence.

Procedure & Fluoroscopy Gallery

High-resolution fluoroscopy imaging capturing the critical phases of the Valve-in-Valve TMVR procedure, lead navigation, and final stable valve seating.

Pre-deployment Imaging and Catheter Alignment
Valve-in-Valve Positioning inside Failed Mitral Ring
Final Deployment and Complete Leaflet Function